Sector ratings Laboratorios Farmaceuticos Rovi, S.A. OTC Markets

Stocks

Delayed OTC Markets 11:30:03 03/08/26 pm AEST			5-day change	1st Jan Change
67.17 ^USD	+1.98%		-.--%	+1.98%

23/07	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
23/07	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
ELI LILLY AND COMPANY	1,043B		A
JOHNSON & JOHNSON	649B	-	BBB	-		-
ABBVIE INC.	469B		AAA			-
ROCHE HOLDING AG	355B		AA
NOVARTIS AG	270B		AAA
ASTRAZENECA PLC	262B		A				-
AMGEN INC.	222B		A
GILEAD SCIENCES, INC.	189B		AA
NOVO NORDISK A/S	175B		BBB
PFIZER INC.	159B		A
VERTEX PHARMACEUTICALS INCORPORATED	131B		AA
BRISTOL-MYERS SQUIBB COMPANY	127B		A
SANOFI	102B		A
GSK PLC	102B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	70.52B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	60.55B		AA
BAYER AG	55.7B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	46.05B		A		-	-		-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	44.97B		AA
Average	238.5B		AA
Weighted average by Cap.			AA